BioCentury
ARTICLE | Company News

Boehringer Ingelheim licenses AbGenomics antibody

June 7, 2005 12:51 AM UTC

AbGenomics (Taipei, Taiwan) granted Boehringer Ingelheim (Ingelheim, Germany) an exclusive worldwide license to develop and commercialize antibody 168 for all indications. The humanized MAb will initi...